Hobart Obesity Surgery-Tony Patiniotis

Hobart Obesity Surgery-Tony Patiniotis holds a 4.5/5 rating across 17 public reviews. The provider consistently scores in the top tier of their category.

Hobart Obesity Surgery-Tony Patiniotis's pricing falls in the "Contact for quote" range. Exact quotes depend on the specific service and scope — request a free written quote to compare before committing.

Hobart Obesity Surgery-Tony Patiniotis is primarily based in Hobart, Australia, and serves clients across Hobart and surrounding areas. Check with the provider directly for specific service-area coverage.

Our independent ranking of the top weight loss clinic in Australia includes Elite Body Contouring Wollongong, Melbourne Weight Loss Centre- Dr. Andrew Huo, Bariatrics Melbourne- Dr Andrew Packiyanathan & Dr Damien Loh. Each has different strengths — see our comparison for a side-by-side breakdown.

Both Wegovy and Mounjaro require a prescription from an Australian doctor. Options: 1) Your GP (most will prescribe with appropriate clinical indication), 2) Endocrinologist or weight loss specialist (referral usually needed), 3) Telehealth platforms like Juniper or Pilot (online consultation, medication delivered). Cost privately: $400-$600/month for the medication plus consultation fees. Wegovy was recommended for PBS listing November 2025 but only for cardiovascular obesity — most patients pay private prices.

Average results from clinical trials: Wegovy (semaglutide) 15% body weight loss over 68 weeks. Mounjaro (tirzepatide) 21% body weight loss over 72 weeks — currently the most effective. Real-world results often slightly lower (12-18%) due to dose adjustments and duration. Important: weight loss plateaus around 12-18 months, and most regain 30-50% of lost weight within a year if medication is stopped without lifestyle changes.

Most common: nausea, vomiting, diarrhoea or constipation, fatigue, mild headaches. These typically improve over 2-4 weeks as your body adjusts. Less common but serious: pancreatitis (1 in 1,000), gallbladder issues, severe dehydration. Long-term safety data beyond 5 years is still emerging. Discuss with your prescriber if you have personal or family history of pancreatic issues, thyroid cancer (specifically MTC), or severe gastrointestinal disease.